MedPage Today on MSN
Cannabinoids for Mental, Substance Use Disorders 'Rarely Justified,' Study Suggests
Cannabis compounds may reduce symptoms for some disorders, but evidence quality is low ...
Two multicenter trials drew different conclusions about the value of conduction system relative to biventricular pacing for left bundle branch block in heart failure.
Methylone is a drug that is thought to enhance neuroplasticity. In a recent clinical trial, this drug led to clinically meaningful improvement in symptoms of PTSD.
OSTEOPATHIC manipulative treatment (OMT) may improve pulmonary function in asthma, though current evidence remains limited ...
Two large phase 3 trials found that oral semaglutide 14 mg did not slow cognitive or functional decline over 104 weeks in ...
MedPage Today on MSN
PSMA-PET Cuts Need for Biopsy in Suspected Prostate Cancer
But does it cost too much?
This study evaluates a new fecal microbiota transplant method, revealing significant symptom improvements in children with ...
BACKGROUND: Premature atrial contractions (PACs) are independently associated with atrial fibrillation, stroke, and heart ...
Enrollment spans Europe, the US, and Canada, targeting ~324 GA patients in a randomized, double-masked, sham-controlled phase ...
Elevated blood pressure (hypertension) is a leading, preventable risk factor for heart disease. Nicotinamide mononucleotide ...
A Swedish national cohort study shows some GLP-1s — semaglutide in particular — are associated with reduced risk of psychiatric decline in patients with depression or anxiety.
Aspen Neuroscience’s stem cell therapy improved Parkinson’s disease symptoms for all eight treated patients after one year, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results